关键词: Anti-calcification Anti-inflammatory Anticoagulant Curcumin Dialdehyde xanthan gum

Mesh : Swine Animals Curcumin / pharmacology Cross-Linking Reagents / chemistry Heart Valve Prosthesis Bioprosthesis Glutaral / chemistry

来  源:   DOI:10.1016/j.carbpol.2023.120724

Abstract:
Currently commercial glutaraldehyde (GA)-crosslinked bioprosthetic valve leaflets (BVLs) suffer from thromboembolic complications, calcification, and limited durability, which are the major stumbling block to wider clinical application of BVLs. Thus, developing new-style BVLs will be an urgent need to enhance the durability of BVLs and alleviate thromboembolic complications. In this study, a quick and effective collaborative strategy of the double crosslinking agents (oxidized polysaccharide and natural active crosslinking agent) was reported to realize enhanced mechanical, and structural stability, excellent hemocompatibility and anti-calcification properties of BVLs. Dialdehyde xanthan gum (AXG) exhibiting excellent stability to heat, acid-base, salt, and enzymatic hydrolysis was first introduced to crosslink decellularized porcine pericardium (D-PP) and then curcumin with good properties of anti-inflammatory, anti-coagulation, anti-liver fibrosis, and anti-atherosclerosis was used to synergistically crosslink and multi-functionalize D-PP to obtain AXG + Cur-PP. A comprehensive evaluation of structural characterization, hemocompatibility, endothelialization potential, mechanical properties and component stability showed that AXG + Cur-PP exhibited better anti-thrombotic properties and endothelialization potential, milder immune responses, excellent anti-calcification properties and enhanced mechanical properties compared with GA-crosslinked PP. Overall, this cooperative crosslinking strategy provides a novel solution to achieve BVLs with enhanced mechanical properties and excellent anti-coagulation, anti-inflammatory, anti-calcification, and the ability to promote endothelial cell proliferation.
摘要:
目前商业戊二醛(GA)-交联的生物瓣膜小叶(BVL)患有血栓栓塞并发症,钙化,和有限的耐用性,这是BVL临床应用的主要绊脚石。因此,开发新型BVL将是增强BVL的耐久性和缓解血栓栓塞并发症的迫切需要。在这项研究中,据报道,双交联剂(氧化多糖和天然活性交联剂)的快速有效的协作策略,以实现增强机械,和结构稳定性,BVL具有优异的血液相容性和抗钙化性能。二醛黄原胶(AXG)表现出优异的热稳定性,酸碱,盐,首先引入酶解交联去细胞猪心包(D-PP),然后再引入具有良好抗炎性能的姜黄素,抗凝,抗肝纤维化,和抗动脉粥样硬化的协同交联和多官能化D-PP获得AXG+Cur-PP。结构表征的综合评价,血液相容性,内皮化潜能,力学性能和组分稳定性表明,AXG+Cur-PP具有较好的抗血栓形成性能和内皮化潜能,更温和的免疫反应,与GA交联的PP相比,优异的抗钙化性能和增强的机械性能。总的来说,这种协同交联策略提供了一种新的解决方案,以实现BVL具有增强的机械性能和优异的抗凝血,抗炎,抗钙化,和促进内皮细胞增殖的能力。
公众号